Healthcare firm Epic BioVentures launches debut fund

Healthcare early stage investor and incubator Epic BioVentures is seeking $125m for its debut Epic BioVentures fund. The firm, which operates through its Atlanta, Minneapolis, Philadelphia and Southern California offices, invests in medtech points to its upfront exit strategy which leads to swift divestments, typically within three to five years. Epic BioVentures is led by …